Working… Menu

Fecal Microbiota Transplant (FMT) in Melanoma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03341143
Recruitment Status : Recruiting
First Posted : November 14, 2017
Last Update Posted : April 13, 2021
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Diwakar Davar, University of Pittsburgh